Gwen Melincoff
Directeur/Membre du Conseil chez GAIN THERAPEUTICS, INC.
Fortune : 521 944 $ au 30/04/2024
Provenance du réseau au premier degré de Gwen Melincoff
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA
31
| Subsidiary | Pharmaceuticals: Major | 31 |
| Public Company | Pharmaceuticals: Major | 28 | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.
19
| Subsidiary | Biotechnology | 19 |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
| Public Company | Biotechnology | 15 | |
| Public Company | Medical Specialties | 13 | |
12
| Public Company | Biotechnology | 12 |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania.
1
| Subsidiary | Investment Managers | 1 |
Vodia Capital LLC
 Vodia Capital LLC Investment ManagersFinance Part of Robertson Stephens Wealth Management LLC, Vodia Capital LLC provides investment advisory services. The private company is based in Concord, MA. The company was founded by David B. Matias. David B. Matias has been the CEO since incorporation. Vodia Capital was acquired by Robertson Stephens Wealth Management LLC on December 13, 2022.
1
| Subsidiary | Investment Managers | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Gwen Melincoff via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| The Hebrew University of Jerusalem | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Graduate Degree Masters Business Admin | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Doctorate Degree Masters Business Admin Graduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member Chief Executive Officer | |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman Corporate Officer/Principal | |
| Protalix Ltd. | Founder Chairman Director/Board Member Director/Board Member | ||
| The College of Management Academic Studies | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing Sales & Marketing | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| XENOPORT, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| NEUBASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| TITAN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SOL-GEL TECHNOLOGIES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Protalix BV | Director/Board Member Director/Board Member | ||
| ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | President President | |
| DYAX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
ADMA Plasma Biologics, Inc.
 ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ. | Biotechnology | Director/Board Member Director/Board Member | |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Director/Board Member Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 36 |
| Israël | 11 |
| Suisse | 2 |
| France | 2 |
| Norvège | 2 |
Sectorielle
| Health Technology | 35 |
| Consumer Services | 12 |
| Finance | 3 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 677 |
| Corporate Officer/Principal | 212 |
| Independent Dir/Board Member | 204 |
| Chairman | 185 |
| Chief Executive Officer | 155 |
Relations les plus connectées
| Insiders | |
|---|---|
| Zeev Bronfeld | 46 |
| Eckard Weber | 46 |
| Pierre Legault | 45 |
| Ernest Mario | 44 |
| Patrick Heron | 42 |
| John Freund | 37 |
| Eliot Forster | 35 |
| Mahendra Shah | 34 |
| Jan Hendrik Egberts | 33 |
| Ambrose Bailey | 32 |
| Khalid Islam | 29 |
| Aharon Schwartz | 29 |
| Bruce Peacock | 28 |
| Dov Goldstein | 28 |
| Hans-Peter Hasler | 28 |
- Bourse
- Insiders
- Gwen Melincoff
- Connexions Sociétés
